Grabenhenrich, Linus B.; Keil, Thomas; Reich, Andreas et al.
Prediction and prevention of allergic rhinitis: A birth cohort study of 20 yearsJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Bd. 136. H. 4. 2015 S. 932-+
Bader, Peter; Rettinger, Eva; Merker, Michael et al.
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center ExperienceBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Bd. 21. H. 2. 2015 S. S209-S209
Frey, G; Schuster, M; Oberlinner, C et al.
Pregnant Employee Protection Program in a Large Chemical Company.J Occup Environ Med. Bd. 57. H. 9. 2015 S. 965-72
Eggermann, T; Brioude, F; Russo, S et al.
Prenatal molecular testing for Beckwith-Wiedemann and Silver-Russell syndromes: a challenge for molecular analysis and genetic counselingEur J Hum Genet. Bd. Oct.28. 2015 S. ff
Rubenwolf, Peter; Ziesel, Christopher; Beetz, Rolf et al.
Presentation, Management and Long-Term Outcome of Ureteropelvic Junction Obstruction in Duplex KidneysJOURNAL OF UROLOGY. Bd. 194. H. 2. 2015 S. 427-432
Neu, M.; Russo, A.; Wingerter, A. et al.
PROSPECTIVE ANALYSIS OF LONG-TERM RENAL FUNCTION IN SURVIVORS OF CHILDHOOD WILMS TUMOR (NEPHROBLASTOMA)PEDIATRIC BLOOD & CANCER. Bd. 62. 2015 S. S219-S219
Damm, Oliver; Eichner, Martin; Rose, Markus Andreas et al.
Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in GermanyEUROPEAN JOURNAL OF HEALTH ECONOMICS. Bd. 16. H. 5. 2015 S. 471-488
Biegstraaten, Marieke; Arngrimsson, Reynir; Barbey, Frederic et al.
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus documentORPHANET JOURNAL OF RARE DISEASES. Bd. 10. 2015
Fieß, A.; Dithmar, S.; Kölb-Keerl, R. et al.
Retinale Blutungen und venöse Stase bei einem 10 Monate alten Säugling nach SturzOphthalmologe. 2015 S. ff
Hiwot, T.; Barohn, R.; Bratkovic, D. et al.
Reveglucosidase alfa (BMN 701), a GILT-tagged recombinant human acid alpha glucosidase (rhGAA), evaluation in late-onset Pompe disease: Preliminary clinical efficacy and safety results of an extension study (72-week results)NEUROMUSCULAR DISORDERS. Bd. 25. 2015 S. S313-S314